Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE LIABILITIES - Schedule of Derivative Liabilities at Fair Value (Details)

v3.24.3
DERIVATIVE LIABILITIES - Schedule of Derivative Liabilities at Fair Value (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2024
Feb. 29, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]            
Balance at beginning of period         $ 2,638  
Derivative warrant issued         6,765  
Fair value changes     $ (2,628) $ 7,460 (2,840) $ (1,660)
Balance at end of period     $ 6,563   $ 6,563  
Granted (in shares)         21,900,000  
Warrants (derivative liabilities and equity)            
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]            
Granted (in shares) 19,400,000 1,800,000